TD ASSET MANAGEMENT INC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$25,795,000
+46.1%
1,108,902
-0.1%
0.04%
+44.4%
Q1 2018$17,650,000
-25.1%
1,109,502
-1.5%
0.03%
-20.6%
Q4 2017$23,562,000
+39.3%
1,126,802
-4.7%
0.03%
+36.0%
Q3 2017$16,911,000
-23.2%
1,182,902
-6.7%
0.02%
-28.6%
Q2 2017$22,007,000
+49.4%
1,268,002
-5.2%
0.04%
+52.2%
Q1 2017$14,732,000
-29.9%
1,337,502
-7.6%
0.02%
-34.3%
Q4 2016$21,020,000
-42.0%
1,447,802
-2.1%
0.04%
-44.4%
Q3 2016$36,218,000
+17.4%
1,478,702
-3.9%
0.06%
+12.5%
Q2 2016$30,857,000
-26.3%
1,538,352
-3.3%
0.06%
-28.2%
Q1 2016$41,886,000
-78.7%
1,591,150
-18.2%
0.08%
-80.1%
Q4 2015$196,885,000
-49.8%
1,944,449
-11.8%
0.39%
-49.4%
Q3 2015$391,892,000
-20.4%
2,204,505
-0.6%
0.77%
-12.2%
Q2 2015$492,345,000
+11.4%
2,218,178
-0.8%
0.88%
+10.2%
Q1 2015$442,008,000
+41.0%
2,235,906
+2.4%
0.80%
+52.9%
Q4 2014$313,397,000
+7.0%
2,183,119
-2.1%
0.52%
+3.4%
Q3 2014$292,795,000
+12.8%
2,229,911
+8.8%
0.50%
+14.3%
Q2 2014$259,650,000
-1.3%
2,050,437
+2.7%
0.44%
-7.7%
Q1 2014$263,126,000
+13.7%
1,996,789
+1.3%
0.48%
+10.9%
Q4 2013$231,325,000
+13.6%
1,972,094
+1.2%
0.43%
+6.7%
Q3 2013$203,617,000
+31.7%
1,949,039
+8.4%
0.40%
+22.0%
Q2 2013$154,605,0001,798,4220.33%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2015
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,586,582$864,160,00032.02%
FARLEY CAPITAL L.P. 341,518$44,807,00030.12%
LeVasseur Capital Partners LLC 190,404$24,981,00029.94%
Ruane, Cunniff & Goldfarb 34,494,015$4,525,615,00023.97%
ValueAct Holdings 18,923,877$2,482,813,00016.64%
White River Investment Partners, LLC 90,099$11,820,00016.35%
Tesuji Partners 1,368,040$179,487,00015.45%
Arrow Capital Management, LLC 197,500$25,912,00015.11%
Hound Partners 3,576,998$469,302,00014.87%
Brahman Capital Corp. 4,457,153$584,778,00012.82%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders